Compare TLX & DRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TLX | DRH |
|---|---|---|
| Founded | 2015 | 2004 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 1.9B |
| IPO Year | N/A | N/A |
| Metric | TLX | DRH |
|---|---|---|
| Price | $9.15 | $9.29 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | ★ $21.13 | $10.08 |
| AVG Volume (30 Days) | 275.4K | ★ 1.8M |
| Earning Date | 04-17-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 3.75% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $2.99 |
| Revenue Next Year | N/A | $2.08 |
| P/E Ratio | $150.33 | ★ $38.41 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.28 | $6.19 |
| 52 Week High | $19.93 | $10.67 |
| Indicator | TLX | DRH |
|---|---|---|
| Relative Strength Index (RSI) | 68.42 | 42.91 |
| Support Level | $8.85 | $9.07 |
| Resistance Level | $9.92 | $9.37 |
| Average True Range (ATR) | 0.25 | 0.23 |
| MACD | 0.11 | -0.01 |
| Stochastic Oscillator | 91.46 | 20.34 |
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
Diamondrock Hospitality Company is a real estate investment trust that owns lodging properties. Its business is to acquire, own, manage, and renovate full-service hotel properties in the United States. It operates in cities such as Chicago, Boston, New York, Denver, and others. Within DiamondRock's holdings, the majority of the hotel brands include Marriott, Starwood, and Hilton. The revenue is divided between room, food and beverage, and others. The room segment contributes the majority of the revenue. The firm's customers include leisure transients, business transients, and group customers.